Large diagnostics laboratory adopts 6-base sequencing to improve disease characterisation

The Munich Leukemia Laboratory (MLL) adopted biomodal’s duet evoC 6-base sequencing technology to enhance disease characterization through high-resolution methylation profiling. The technology demonstrated improved ease of use, deep genomic coverage, and low background noise, providing promising results for patient stratification and biomarker discovery in leukemia diagnostics.